DLBCL Video Channel
Explore the latest insights and summaries from experts in DLBCL.
Treatment Landscape
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in DLBCL and HL
FEATURING
Julie Erika Haydu
- 310 views
- June 5, 2024
- 3
Dipenkumar Modi
Current Management of DLBCL From Frontline to Relapsed Disease
- 334 views
- June 5, 2024
Gerardo Musuraca
Managing R/R DLBCL: Bispecific Antibodies and the "Surface Epitopes Strategy"
- 72 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,289 views
- June 19, 2024
- 2
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 240 views
- July 8, 2024
SOHO Brazil 2024
Has the 1L SoC Truly Changed in Advanced Stage DLBCL?
FEATURING
Andrew Zelenetz
- 567 views
- July 11, 2024
- 3
SOHO Brazil 2024
Summary of Updates in R/R DLBCL Treatment
FEATURING
Alvaro Alencar
- 109 views
- July 11, 2024
SOHO Brazil 2024
DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We Treat Them?
FEATURING
Andrew Zelenetz
- 126 views
- July 11, 2024
SOHO Brazil 2024
What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy in LBCL?
FEATURING
Andrew Zelenetz
- 57 views
- July 11, 2024
UChicago Medicine
How to Assess and Treat Elderly Patients With DLBCL
FEATURING
Stefano Luminari
- 76 views
- July 22, 2024
UChicago Medicine
Sequencing of Bispecifics With Other Therapies in DLBCL
FEATURING
Elizabeth Budde
- 347 views
- July 29, 2024
Integrity CE
Treatment Updates and Management of Non-Hodgkin Lymphomas
FEATURING
Danielle Wallace,
Matthew Cortese
- 103 views
- August 7, 2024
- 1
MyCancerHaven
Recent Updates on Liso-Cel in R/R DLBCL & MCL
FEATURING
Ravi Vij,
Forat Lutfi
- 44 views
- August 30, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: HL, DLBCL, MCL
FEATURING
Alexandra Rojek
- 127 views
- September 4, 2024
- 2
Houston Methodist
What's Current in Immunotherapy in DLBCL and FL
FEATURING
Amitkumar Mehta
- 104 views
- September 10, 2024
Yale Cancer Center
Caring for Patients With Lymphoma: Using Guidelines to Improve Quality of Care
FEATURING
Scott Huntington,
Eric Winer
- 77 views
- September 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 469 views
- September 23, 2024
- 2
Patrizia Mondello
Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLBCL
- 184 views
- September 30, 2024
Sarah Rutherford
Optimizing 2L DLBCL Treatment Strategies for CAR-T Ineligible Patients
- 66 views
- October 15, 2024
University of Colorado Division of Hematology
DLBCL: How Do We Choose Initial Therapy?
FEATURING
Caroline Pearson
- 24 views
- October 21, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Updates in DLBCL: Insights on Treatment and Research
FEATURING
John Lister
- 34 views
- October 21, 2024
- 1
Yale Cancer Center
Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL
FEATURING
Tarsheen Sethi
- 185 views
- October 21, 2024
- 1
Yale Cancer Center
DLBCL Case Discussion: Strategies for 3L Management
FEATURING
Scott Huntington,
Iris Isufi
- 40 views
- October 22, 2024
- 1
Vanderbilt University Medical Center (VUMC)
Updates in CAR-T Therapy for Aggressive Lymphomas
FEATURING
Bhagirathbhai Dholaria
- 97 views
- October 23, 2024
- 1
Joseph Mikhael
The Relapsed and Refractory MM Patient: When Immune Approaches Are Ineffective
- 100 views
- November 10, 2024
- 2
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
FEATURING
Manali Kamdar
- 252 views
- April 8, 2024
- 1
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do and Know in Community Oncology Practice
FEATURING
Tycel Phillips
- 152 views
- April 23, 2024
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lymphomas
FEATURING
Sonali Smith
- 665 views
- April 23, 2024
- 7
Indy Hematology Review
2024 Updates on Understanding & Managing Immune Effector Cell Toxicities in Hematologic Malignancies
FEATURING
David Reeves
- 243 views
- April 30, 2024
- 2
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
FEATURING
Pallawi Torka
- 376 views
- May 2, 2024
MyCancerHaven
Frontline DLBCL Treatment Approaches
FEATURING
Ravi Vij,
Hua-Jay Cherng
- 321 views
- May 13, 2024
- 1
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL
FEATURING
Shalin Kothari
- 132 views
- May 13, 2024
UChicago Medicine
Improving Lymphoma Outcomes: Optimizing Trial Design, Using Surrogate Endpoints, and Incorporating Guidelines
FEATURING
Andrew Zelenetz
- 106 views
- July 22, 2024
- 1
University of Colorado Cancer Center
Managing R/R LBCL Patients Treated With Pola-R-CHP in 1L and Are CAR-T Ineligible
FEATURING
Manali Kamdar
- 109 views
- November 21, 2024
- 2
UNC Lineberger Comprehensive Cancer Center
2024 Updates in the Management of DLBCL, FL, and HL
FEATURING
Anne Beaven
- 37 views
- November 26, 2024
- 1
Moffitt Cancer Center
R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?
FEATURING
Aleksandr Lazaryan
- 332 views
- March 11, 2024
- 1
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Lymphoid Diseases
- 46 views
- March 11, 2024
Scripps Health
New Updates in Frontline DLBCL
FEATURING
Loretta Nastoupil
- 704 views
- March 21, 2024
- 5
Scripps Health
Update in the Treatment of R/R DLBCL
FEATURING
Charalambos Andreadis
- 234 views
- March 28, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: B-Cell Lymphoma
FEATURING
Loretta Nastoupil
- 435 views
- March 29, 2024
- 3
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Aggressive B-Cell Lymphomas
FEATURING
Grzegorz Nowakowski
- 395 views
- March 29, 2024
- 3
Megan Melody
Sequencing Cellular Therapy and Bispecific Antibodies in DLBCL
- 112 views
- December 2, 2024
- 4
Grzegorz Nowakowski
Current Approaches and Ongoing Trials in Frontline DLBCL Treatment
- 16 views
- December 13, 2024
Louisville Hematology Highlights
2024 Updates on Management of DLBCL
FEATURING
John Leonard
- 99 views
- December 13, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Optimizing Tafa-Len in R/R DLBCL - GELTAMO Real-World Study
FEATURING
Antonio Gutierrez
- 13 views
- December 16, 2024
- 1
Remy Dulery
Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy
- 19 views
- December 17, 2024